COMMUNIQUÉS West-GlobeNewswire

-
Nutra Pharma Corp. Reaches Settlement with SEC
22/03/2024 -
IBEX Reports Results for the Second Quarter and Six Months Ended January 31, 2024
22/03/2024 -
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/03/2024 -
Alvotech Announces Increase in Number of Own Shares
22/03/2024 -
Alvotech Announces Increase in Number of Own Shares
22/03/2024 -
Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
22/03/2024 -
Veru Reschedules Annual Meeting of Shareholders
22/03/2024 -
Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results
22/03/2024 -
Inventiva annonce la date de publication et de présentation de ses résultats financiers 2023
22/03/2024 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22/03/2024 -
Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial
22/03/2024 -
TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
22/03/2024 -
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
22/03/2024 -
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
22/03/2024 -
Nextech Demos Patient Journey Innovations with Artificial Intelligence for Specialty Practices
22/03/2024 -
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
22/03/2024 -
Join Lytus Technologies’ Exclusive Live Investor Webinar and Q&A Session on March 27
22/03/2024 -
Theratechnologies Announces Update on its Preclinical Oncology Research Program
22/03/2024 -
Theratechnologies fait le point sur son programme de recherche préclinique en oncologie
22/03/2024
Pages